首页> 外文期刊>Journal of oncology >Development of a Score Predicting Survival after Palliative Reirradiation
【24h】

Development of a Score Predicting Survival after Palliative Reirradiation

机译:缓解再照射后生存率的评分发展

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose. To develop a prognostic model for predicting survival after palliative reirradiation (PR). Methods and Materials. We analyzed all 87 PR courses administered at a dedicated palliative radiotherapy facility between 20.06.2007 (opening) and 31.12.2009. Uni- and multivariate survival analyses were performed, the previously published survival prediction score (SPS) was evaluated, and a PR-specific prognostic score was calculated. Results. In multivariate analysis, four parameters significantly influenced survival: performance status, use of steroids, presence of liver metastases, and pleural effusion. Based on these parameters, a 4-tiered score was developed. Median survival was 24.5 months for the favorable group, 9.7 and 2.8 months for the two intermediate groups, and 1.1 months for the unfavorable group (P = 0.019 for comparison between the two favorable groups and P < 0.002 for all other pair-wise comparisons). All patients in the unfavorable group died within 2 months. Conclusion. The performance of PR-specific score was promising and might facilitate identification of patients who survive long enough to benefit from PR. It should be validated in independent patient groups, ideally from several institutions and countries.
机译:目的。建立预测姑息再照射(PR)后生存的预后模型。方法和材料。我们分析了在2007年6月20日(开业)至2009年12月31日之间在专用姑息放疗设施实施的所有87门PR课程。进行单变量和多变量生存分析,评估先前公布的生存预测评分(SPS),并计算PR特异性预后评分。结果。在多变量分析中,四个参数显着影响了生存率:生产状况,类固醇的使用,肝转移的存在和胸腔积液。基于这些参数,开发了4层评分。有利组的中位生存期为24.5个月,两个中间组为9.7和2.8个月,不利组为1.1个月(两个有利组之间的比较,P = 0.019,所有其他成对比较,P <0.002) 。不利组中的所有患者均在2个月内死亡。结论。 PR特异性评分的表现令人鼓舞,并且可能有助于鉴定存活时间足够长的患者,以受益于PR。应该在独立的患者组中进行验证,最好是在几个机构和国家/地区进行验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号